According to the WHO, around 700,000 to 1 million cases of leishmaniasis occur annually worldwide. Leishmaniasis, a protozoan disease, is prevalent in regions with malnutrition, poor sanitation, population mobility, and climatic changes. In addition, infections such as HIV and Kala-azar disease predispose the affected individuals to leishmaniasis. Therefore, identifying and addressing the gaps and challenges concerning its diagnosis and early therapeutic interventions is essential to reduce its global burden.
To learn more about leishmaniasis, join this exclusive session on “ Leishmaniasis: Knowledge Gaps and Challenges ” by the expert, Prof. Shyam Sundar , on 18 th December, 6:00 PM IST onwards. Highlights Diagnosis of visceral leishmaniasis Drug resistance New treatment guidelines Stay tuned!
